Copyright
©The Author(s) 2020.
World J Clin Cases. Feb 26, 2020; 8(4): 658-669
Published online Feb 26, 2020. doi: 10.12998/wjcc.v8.i4.658
Published online Feb 26, 2020. doi: 10.12998/wjcc.v8.i4.658
Table 2 Characteristics of 30 gastric signet ring cell carcinoma and 30 adenocarcinoma patients, n (%)
Characteristic | Overall (n = 60) | GSRCC (n = 30) | Adenocarcinoma (n = 30) | P value |
Age (yr) | 0.052 | |||
≤ 65 | 41 (68.3) | 24 (80.0) | 17 (56.7) | |
> 65 | 19 (31.7) | 6 (20.0) | 13 (43.3) | |
Gender | 0.584 | |||
Male | 40 (66.7) | 21 (70.0) | 19 (63.3) | |
Female | 20 (33.3) | 9 (30.0) | 11 (36.7) | |
Tumor size (cm) | 0.584 | |||
≤ 5 | 40 (66.7) | 21 (70.0) | 19 (63.3) | |
> 5 | 20 (33.3) | 9 (30.0) | 11 (36.7) | |
Lauren type | 0 | |||
Intestinal | 12 (20.0) | 0 (0) | 12 (40.0) | |
Diffuse | 35 (58.3) | 26 (86.7) | 9 (30.0) | |
Mixed | 12 (20.0) | 4 (13.3) | 8 (26.7) | |
Unknown | 1 (1.67) | 0 (0) | 1 (3.3) | |
Histology differentiation | 0.038 | |||
Poorly/un-differentiated | 56 (93.3) | 30 (100.0) | 26 (86.7) | |
Well/moderately differentiated | 4 (6.7) | 0 (0) | 4 (13.3) | |
Unknown | ||||
T stage | 0.725 | |||
T1 | 5 (8.3) | 3 (10.0) | 2 (6.7) | |
T2 | 9 (15.0) | 3 (10.0) | 6 (20.0) | |
T3 | 12 (20.0) | 6 (20.0) | 6 (20.0) | |
T4 | 34 (56.7) | 18 (60.0) | 16 (53.3) | |
N stage | 0.639 | |||
N0 | 16 (26.7) | 8 (26.7) | 8 (26.7) | |
N1 | 6 (10.0) | 3 (10.0) | 3 (10.0) | |
N2 | 20 (33.3) | 8 (26.7) | 12 (40.0) | |
N3 | 18 (30.0) | 11 (36.7) | 7 (23.3) | |
M stage | 0.15 | |||
Metastasis | 2 (3.3) | 2 (6.7) | 0 (0) | |
No metastasis | 58 (96.7) | 28 (93.3) | 30 (100.0) | |
Positive lymph nodes | 0.39 | |||
≤ 8 | 43 (71.7) | 20 (66.7) | 23 (76.7) | |
> 8 | 17 (28.3) | 10 (33.3) | 7 (23.3) | |
Lymphovascular invasion | 0.355 | |||
Yes | 31 (51.7) | 15 (50.0) | 16 (53.3) | |
No | 27 (45.0) | 13 (43.3) | 14 (46.7) | |
Unknown | 2 (3.3) | 2 (6.7) | 0 (0) | |
Nerve invasion | 0.213 | |||
Yes | 42 (70.0) | 22 (73.3) | 20 (66.7) | |
No | 16 (26.7) | 6 (20) | 10 (33.3) | |
Unknown | 2 (3.3) | 2 (6.7) | 0 (0) | |
Neoadjuvant chemotherapy | 0.688 | |||
Yes | 7 (88.3) | 4 (13.3) | 3 (10.0) | |
No | 53 (11.7) | 26 (86.7) | 27 (90.0) |
- Citation: Zhao ZT, Li Y, Yuan HY, Ma FH, Song YM, Tian YT. Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis. World J Clin Cases 2020; 8(4): 658-669
- URL: https://www.wjgnet.com/2307-8960/full/v8/i4/658.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i4.658